Astonea Labs Share Price
414.00+0.00 (+0.98%)
+191.34% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
ASTONEALAB-MNSE
Astonea Labs Share Price
414.00+0.00 (+0.98%)
+191.34% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 51% |
| - | - | - | -16% |
| - | - | - | 191% |
| 21% | 21% | 21% | 12% |
Peer Comparison
Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
LAURUSLABS-A
ZYDUSLIFE-A
DRREDDY-A
CIPLA-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
ASTONEALAB-M
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,885.1 | ₹456593 Cr | 41.64 | 8.29 | 58.23 | ₹11479 Cr |
| 11,200 | ₹296741 Cr | 88.24 | 42.53 | 146.01 | ₹2568 Cr |
| 4,698.8 | ₹175578 Cr | 82.66 | 14.04 | 106.21 | ₹2163 Cr |
| 2,295 | ₹124380 Cr | 92.83 | 8.17 | 33.94 | ₹889 Cr |
| 1,195.05 | ₹119700 Cr | 28.64 | 9.27 | 62.23 | ₹5040 Cr |
| 1,390.5 | ₹116771 Cr | 41.71 | 11.08 | 59.16 | ₹4196 Cr |
| 1,414.95 | ₹114397 Cr | 39.49 | 10.86 | 52.6 | ₹3879 Cr |
| 2,660 | ₹108641 Cr | 48.44 | 17.23 | 76.25 | ₹1913 Cr |
| 1,795.3 | ₹103971 Cr | 26.06 | 19.57 | 103.44 | ₹3505 Cr |
| 2,010 | ₹91413 Cr | 17.56 | 25.26 | 150.99 | ₹5333 Cr |
| 414 | ₹431 Cr | 95.44 | 4.53 | 9.04 | ₹5 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 |
|---|---|
| — | — |
| ₹11 Cr | ₹8 Cr |
| ₹47 Cr | ₹11 Cr |
| ₹47 Cr | ₹11 Cr |
| ₹57 Cr | ₹18 Cr |
| ₹18 Cr | ₹16 Cr |
| ₹3 Cr | ₹4 Cr |
| -₹55 L | ₹3 L |
| ₹8 L | ₹0 |
| ₹43 L | ₹33 L |
| ₹21 Cr | ₹20 Cr |
| — | — |
| ₹40 Cr | ₹26 Cr |
| ₹8 Cr | ₹8 Cr |
| ₹19 Cr | ₹29 Cr |
| ₹2 Cr | ₹2 Cr |
| ₹69 Cr | ₹65 Cr |
| ₹147 Cr | ₹104 Cr |
| ₹4 Cr | ₹9 Cr |
| ₹43 Cr | ₹53 Cr |
| — | — |
| ₹31 Cr | ₹26 Cr |
| ₹31 Cr | ₹26 Cr |
| ₹8 Cr | ₹4 Cr |
| ₹6 Cr | ₹0 |
| ₹6 Cr | ₹0 |
| ₹30 L | ₹29 L |
| ₹2 Cr | ₹2 Cr |
| ₹48 Cr | ₹33 Cr |
| — | — |
| ₹34 Cr | ₹29 Cr |
| ₹52 Cr | ₹38 Cr |
| ₹18 L | ₹9 L |
| ₹84 L | ₹33 L |
| ₹13 Cr | ₹4 Cr |
| ₹100 Cr | ₹71 Cr |
| ₹30 Cr | ₹6 Cr |
| ₹147 Cr | ₹104 Cr |
| ₹54 | ₹24 |
| ₹54 | ₹24 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 |
|---|---|
| ₹6 Cr | ₹7 Cr |
| ₹8 Cr | ₹8 Cr |
| -₹24 Cr | -₹2 Cr |
| -₹10 Cr | ₹13 Cr |
| -₹14 Cr | ₹9 Cr |
| -₹20 Cr | -₹11 Cr |
| ₹34 Cr | ₹2 Cr |
| ₹9 L | -₹27 L |
| ₹9 L | ₹36 L |
| ₹18 L | ₹9 L |
Fundamental Ratios
Consolidated
Standalone

No results found
Astonea Labs Share Price
414.00+0.00 (+0.98%)
+191.34% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 4 out of 9 oscillators
RSI
77.14Buy
STOCH %K
93.81Sell
MACD Level(12,26)
25.66Buy
Ultimate Oscillator
73.40Buy
Aroon Oscillator
60.00Buy
BOP
-0.45Sell
CCI
158.52Sell
Williams %R
-6.19Sell
Momentum
90.00Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 9
Bearish signals: 0 out of 9 moving averages
EMA 9
386.77Buy
SMA 9
380.07Buy
EMA 21
360.30Buy
SMA 21
354.04Buy
EMA 50
324.69Buy
SMA 50
315.62Buy
EMA 200
242.13Buy
SMA 200
215.12Buy
WMA 20
368.43Buy
Pivot
Pivot
Classic
Resistance 5
464.33
Resistance 4
451.33
Resistance 3
438.33
Resistance 2
425.33
Resistance 1
417.67
Pivot
412.33
Support 1
404.67
Support 2
399.33
Support 3
386.33
Support 4
373.33
Support 5
360.33
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Astonea Labs Share Price
414.00+0.00 (+0.98%)
+191.34% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Mar 2026 | Sep 2025 |
|---|---|---|
| 72.44% | 72.30% | 72.30% |
| 0.00% | 0.00% | 2.51% |
| 0.00% | 0.07% | 0.35% |
| 0.00% | 0.00% | 0.00% |
| 27.56% | 27.63% | 24.84% |
Bulk & block deals
Name
Swati Agarwala
Swati Agarwala
Nu Heights Agency Private Limited
Padmawati Realcon Private Limited
Vivekgujrani
Vivekgujrani
Basan Equity Broking Limited
Vivekgujrani
Caravan Properties Private Limited
Astorne Capital Vcc Arven
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 07 May 2026 | Sell | 1.11 Cr | ₹168.78 | 66 K | Bulk | 0.627914 | BSE |
| 06 May 2026 | Sell | 1.74 Cr | ₹166 | 1.05 L | Bulk | 0.998953 | BSE |
| 26 Nov 2025 | Purchase | 1.35 Cr | ₹149.59 | 90 K | Bulk | 0.856246 | BSE |
| 26 Nov 2025 | Purchase | 1.05 Cr | ₹150.41 | 70 K | Bulk | 0.665969 | BSE |
| 24 Nov 2025 | Purchase | 7 L | ₹139.99 | 5 K | Bulk | 0.047569 | BSE |
| 24 Nov 2025 | Sell | 64.11 L | ₹118.73 | 54 K | Bulk | 0.513748 | BSE |
| 12 Nov 2025 | Sell | 75.61 L | ₹140.02 | 54 K | Bulk | 0.513748 | BSE |
| 03 Jun 2025 | Purchase | 6.48 Cr | ₹137.58 | 4.71 L | Bulk | 4.48102 | BSE |
| 03 Jun 2025 | Purchase | 85.27 L | ₹137.53 | 62 K | Bulk | 0.589858 | BSE |
| 03 Jun 2025 | Sell | 1.17 Cr | ₹137.49 | 85 K | Bulk | 0.808677 | BSE |
Insider trading & SAST
Client name
Ashish Gulati
Ashish Gulati
Ashish Gulati
Ashish Gulati
Ashish Gulati
Ashish Gulati
Ashish Gulati
Ashish Gulati
Ashish Gulati
Vivek Gujrani
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 Sep 2026 | Promoter | Acquisition | 0.028542 | 70.94 | 9.40 L | ₹313.50 | 3 K | 16 Sep 2026 | Market Purchase | 74,56,970 | Insider Trading | — | Equity |
| 17 Sep 2026 | Promoter | Acquisition | 0.009514 | 70.87 | 2.98 L | ₹298.50 | 1 K | 16 Sep 2026 | Market Purchase | 74,48,970 | Insider Trading | — | Equity |
| 17 Sep 2026 | Promoter | Acquisition | 0.009514 | 70.92 | 3.13 L | ₹313 | 1 K | 16 Sep 2026 | Market Purchase | 74,53,970 | Insider Trading | — | Equity |
| 17 Sep 2026 | Promoter | Acquisition | 0.028542 | 70.85 | 8.91 L | ₹297 | 3 K | 16 Sep 2026 | Market Purchase | 74,46,970 | Insider Trading | — | Equity |
| 17 Sep 2026 | Promoter | Acquisition | 0.019028 | 70.9 | 6.20 L | ₹310 | 2 K | 16 Sep 2026 | Market Purchase | 74,51,970 | Insider Trading | — | Equity |
| 17 Sep 2026 | Promoter | Acquisition | 0.009514 | 70.91 | 3.12 L | ₹312 | 1 K | 16 Sep 2026 | Market Purchase | 74,52,970 | Insider Trading | — | Equity |
| 17 Sep 2026 | Promoter | Acquisition | 0.009514 | 70.88 | 3 L | ₹299.50 | 1 K | 16 Sep 2026 | Market Purchase | 74,49,970 | Insider Trading | — | Equity |
| 17 Sep 2026 | Promoter | Acquisition | 0.009514 | 70.82 | 2.85 L | ₹285 | 1 K | 15 Sep 2026 | Market Purchase | 74,43,970 | Insider Trading | — | Equity |
| 17 Sep 2026 | Promoter | Acquisition | 0.009514 | 70.86 | 2.98 L | ₹297.50 | 1 K | 16 Sep 2026 | Market Purchase | 74,47,970 | Insider Trading | — | Equity |
| 05 Jul 2025 | Other | Acquisition | 5.64 | 5.64 | 0 | — | 5.93 L | 03 Jun 2025 - 13 Jun 2025 | Market | 5,93,000 | SAST | 29(1) | — |
Astonea Labs Share Price
414.00+0.00 (+0.98%)
+191.34% past 1 Year
Astonea Labs specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anti-cold medications, antihistamines, and drugs for diabetes, cardiovascular diseases,
Corporate Actions
Date
Type
Details
Company details
Astonea Labs Share Price
414.00+0.00 (+0.98%)
+191.34% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Astonea Labs Share Price
414.00+0.00 (+0.98%)
+191.34% past 1 Year
News
1 of 5
Stock NewsASTONEALAB27 Apr 2026
NULL
Astonea Labs informs about updates
Stock NewsASTONEALAB23 Apr 2026
NULL
Astonea Labs incorporates wholly owned subsidiary in USA
Stock NewsASTONEALAB27 Jan 2026
The Astonea LLC has been incorporated for the purpose of carrying on the business of Pharmaceuticals, Food Supplements and Cosmetics
Astonea Labs informs about resignation of CS cum CO
Stock NewsASTONEALAB11 Jun 2025
NULL
Astonea Labs informs about resignation of CS cum CO
Stock NewsASTONEALAB11 Jun 2025
NULL

